MedPath

Exploring the Effect of the Transcendental Meditation® Technique on Migraine Frequency and Functionality: a Single Arm Study

Not Applicable
Recruiting
Conditions
Migraine
Migraine with or Without Aura
Registration Number
NCT06695156
Lead Sponsor
Maharishi International University
Brief Summary

This research will explore the effect of the Transcendental Meditation® Technique on migraine intensity and frequency. It will be a single-arm pilot study involving 30 participants recruited from migraine treatment facilities and support groups in the US.

Detailed Description

The objective of this study is to assess the safety, feasibility, and effects of the practice of the Transcendental Meditation technique in adults with migraines. This study will involve 30 participants recruited from migraine treatment facilities and migraine support groups in the US. The study will span three months, with all participants practicing Transcendental Meditation (TM) while continuing their usual lifestyle and medication regimen. Pre-data will be collected through symptom analysis, headache patterns, and evaluation questionnaires. All potential subjects will keep a daily migraine diary for 30 days before inclusion in the study, both to assess migraine status and to adhere to study protocols during the study. All the subjects will receive TM instruction, followed by bi-weekly group meetings and one-on-one sessions for 3 months to monitor progress and ensure correct practice.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Frequency and functionality6 Months

Frequency and functionality will be measured by the data recorded in the migraine App.

The Migraine Disability Assessment (MIDAS) to measure frequency and functionality.6 Months
Migraine Specific Quality of Life Questionnaire (MSQ), version 2.1 to measure impact on Quality of Life6 Months
Questionnaire (MSQ), version 2.1 to measure impact on functionality.6 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Georgetown Headache Center and DC area

🇺🇸

Washington, District of Columbia, United States

© Copyright 2025. All Rights Reserved by MedPath